Antidepressant prescribing patterns among VA patients with schizophrenia

Schizophrenia Research

Volumn 136, Issue 1-3, 2012, Pages 32-35

  Himelhoch, Seth ^a   Slade, Eric ^a   Kreyenbuhl, Julie ^a   Medoff, Deborah ^a   Brown, Clayton ^a   Dixon, Lisa ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Schizophrenia; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VETERANS;

EID: 84857997491     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.01.008     Document Type: Article

References (18)

1. Addington D., Addington J., Patten S., Remington G., Moamai J., Labelle A., Beauclair L. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J. Clin. Psychopharmacol. 2002, 22:20-25.
2. Barnes T.R. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 2011, 25:567-620.
3. Buchanan R.W., Kreyenbuhl J., Kelly D.L., Noel J.M., Boggs D.L., Fischer B.A., Himelhoch S., Fang B., Peterson E., Aquino P.R., Keller W. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr. Bull. 2010, 36:71-93.
4. Chakos M.H., Glick I.D., Miller A.L., Hamner M.B., Miller D.D., Patel J.K., Tapp A., Keefe R.S., Rosenheck R.A. Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr. Serv. 2006, 57:1094-1101.
5. Daniel D.G., Randolph C., Jaskiw G., Handel S., Williams T., Abi-Dargham A., Shoaf S., Egan M., Elkashef A., Liboff S., et al. Coadministration of fluvoxamine increases serum concentrations of haloperidol. J. Clin. Psychopharmacol. 1994, 14:340-343.
6. Lam J.A., Rosenheck R.A. Correlates of improvement in quality of life among homeless persons with serious mental illness. Psychiatr. Serv. 2000, 51:116-118.
7. Lehman A.F., Kreyenbuhl J., Buchanan R.W., Dickerson F.B., Dixon L.B., Goldberg R., Green-Paden L.D., Tenhula W.N., Boerescu D., Tek C., Sandson N., Steinwachs D.M. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr. Bull. 2004, 30:193-217.
8. McCarthy J.F., Blow F.C., Valenstein M., Fischer E.P., Owen R.R., Barry K.L., Hudson T.J., Ignacio R.V. Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Serv Res. 2007, 42:1042-1060.
9. Mojtabai R., Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch. Gen. Psychiatry 2010, 67:26-36.
10. Möller H.J. Drug treatment of depressive symptoms in schizophrenia. Clin. Schizophr. Relat. Psychoses 2008, 1:328-340.
11. Mulholland C., Lynch G., King D.J., Cooper S.J. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. J. Psychopharmacol. 2003, 17:107-112.
12. Nemeroff C.B., DeVane C.L., Pollock B.G. Newer antidepressants and the cytochrome P450 system. Am. J. Psychiatry 1996, 153:311-320.
13. Rummel C., Kissling W., Leucht S. Antidepressants for the negative symptoms of schizophrenia. Cochrane Database Syst Rev 2006, 3. CD005581.
14. Sajatovic M., Valenstein M., Blow F.C., Ganoczy D., Ignacio R.V. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006, 8:232-241.
15. Sepehry A.A., Potvin S., Elie R., Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J Clin Psychiatry. 2007, 68:604-610.
16. Silver H. Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. Expert. Opin. Pharmacother. 2004, 5:2053-2058.
17. Singh S.P., Singh V., Kar N., Chan K. Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br. J. Psychiatry 2010, 197:174-179.
18. Whitehead C., Moss S., Cardno A., Lewis G. Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev. 2002, CD002305.